Walleye Trading LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$240,664
-54.3%
20,982
+0.8%
0.00%
-100.0%
Q2 2023$526,625
-32.6%
20,807
-14.2%
0.00%
-50.0%
Q1 2023$781,157
-38.3%
24,252
-64.6%
0.00%
-33.3%
Q4 2022$1,266,042
-57.8%
68,583
-38.2%
0.00%
-66.7%
Q3 2022$2,997,000
+277.0%
110,988
+93.0%
0.01%
+200.0%
Q2 2022$795,000
-59.4%
57,498
-42.7%
0.00%
-50.0%
Q1 2022$1,956,000
+210.0%
100,300
+159.7%
0.01%
+200.0%
Q4 2021$631,000
+45.1%
38,620
+147.6%
0.00%
+100.0%
Q3 2021$435,000
-71.3%
15,600
-69.5%
0.00%
-83.3%
Q2 2021$1,514,000
-18.3%
51,091
-21.9%
0.01%
-25.0%
Q4 2020$1,853,000
+808.3%
65,400
+707.4%
0.01%
+700.0%
Q3 2020$204,000
-61.8%
8,100
-62.3%
0.00%
-66.7%
Q3 2018$534,000
+30.2%
21,501
+43.9%
0.00%
+50.0%
Q2 2018$410,00014,939
+373375.0%
0.00%
Q4 2015$0
-100.0%
4
-98.7%
0.00%
Q2 2015$10,0003000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders